Christian Barro
Christian Barro
Postdoctoral fellow, Harvard Medical School
Verified email at
Cited by
Cited by
Neurofilaments as biomarkers in neurological disorders
M Khalil, CE Teunissen, M Otto, F Piehl, MP Sormani, T Gattringer, ...
Nature Reviews Neurology 14 (10), 577-589, 2018
Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis
G Disanto, C Barro, P Benkert, Y Naegelin, S Schädelin, A Giardiello, ...
Annals of neurology 81 (6), 857-870, 2017
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
J Kuhle, C Barro, U Andreasson, T Derfuss, R Lindberg, Å Sandelius, ...
Clinical Chemistry and Laboratory Medicine (CCLM) 54 (10), 1655-1661, 2016
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
O Preische, SA Schultz, A Apel, J Kuhle, SA Kaeser, C Barro, S Gräber, ...
Nature medicine 25 (2), 277-283, 2019
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
C Barro, P Benkert, G Disanto, C Tsagkas, M Amann, Y Naegelin, ...
Brain 141 (8), 2382-2391, 2018
Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
J Kuhle, C Barro, G Disanto, A Mathias, C Soneson, G Bonnier, Ö Yaldizli, ...
Multiple Sclerosis Journal 22 (12), 1550-1559, 2016
Neurofilament light chain: a biomarker for genetic frontotemporal dementia
LH Meeter, EG Dopper, LC Jiskoot, R Sanchez‐Valle, C Graff, L Benussi, ...
Annals of clinical and translational neurology 3 (8), 623-636, 2016
Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
J Kuhle, H Kropshofer, DA Haering, U Kundu, R Meinert, C Barro, ...
Neurology 92 (10), e1007-e1015, 2019
Serum neurofilament is associated with progression of brain atrophy and disability in early MS
J Kuhle, B Nourbakhsh, D Grant, S Morant, C Barro, Ö Yaldizli, D Pelletier, ...
Neurology 88 (9), 826-831, 2017
Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
N Siller, J Kuhle, M Muthuraman, C Barro, T Uphaus, S Groppa, L Kappos, ...
Multiple Sclerosis Journal 25 (5), 678-686, 2019
Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis
E Feneberg, P Oeckl, P Steinacker, F Verde, C Barro, P Van Damme, ...
Neurology 90 (1), e22-e30, 2018
Serum neurofilament light is sensitive to active cerebral small vessel disease
T Gattringer, D Pinter, C Enzinger, T Seifert-Held, M Kneihsl, S Fandler, ...
Neurology 89 (20), 2108-2114, 2017
Neurofilament light chain predicts disease activity in relapsing-remitting MS
KN Varhaug, C Barro, K Bjørnevik, KM Myhr, Ø Torkildsen, S Wergeland, ...
Neurology-Neuroimmunology Neuroinflammation 5 (1), 2018
Serum neurofilament light: a biomarker of neuroaxonal injury after ischemic stroke
S Tiedt, M Duering, C Barro, AG Kaya, J Boeck, FJ Bode, M Klein, F Dorn, ...
Neurology 91 (14), e1338-e1347, 2018
Neurofilament light chain serum levels correlate with 10‐year MRI outcomes in multiple sclerosis
T Chitnis, C Gonzalez, BC Healy, S Saxena, M Rosso, C Barro, ...
Annals of clinical and translational neurology 5 (12), 1478-1491, 2018
Serum neurofilament light chain in patients with acute cerebrovascular events
GM De Marchis, M Katan, C Barro, J Fladt, C Traenka, DJ Seiffge, L Hert, ...
European journal of neurology 25 (3), 562-568, 2018
Association between serum neurofilament light chain levels and long-term disease course among patients with multiple sclerosis followed up for 12 years
E Cantó, C Barro, C Zhao, SJ Caillier, Z Michalak, R Bove, D Tomic, ...
JAMA neurology 76 (11), 1359-1366, 2019
Serum neurofilament light levels in normal aging and their association with morphologic brain changes
M Khalil, L Pirpamer, E Hofer, MM Voortman, C Barro, D Leppert, ...
Nature communications 11 (1), 1-9, 2020
Serum neurofilament light chain levels in patients with presymptomatic multiple sclerosis
K Bjornevik, KL Munger, M Cortese, C Barro, BC Healy, DW Niebuhr, ...
JAMA neurology 77 (1), 58-64, 2020
Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD
M Watanabe, Y Nakamura, Z Michalak, N Isobe, C Barro, D Leppert, ...
Neurology 93 (13), e1299-e1311, 2019
The system can't perform the operation now. Try again later.
Articles 1–20